Efficacy and tolerability of various bowel preparations in diabetic patients: a randomized controlled trial.

 Diabetes mellitus (DM) is an independent risk factor for poor bowel preparation prior to colonoscopy. Bisacodyl is a stimulant laxative that may mitigate colonic dysmotility associated with diabetes. We hypothesized that adding bisacodyl to split-dose bowel preparation (SDBP) would improve the quality of bowel preparation among patients with diabetes.

The frequency of histologically confirmed Barrett's esophagus varies by the combination of ethnicity and gender.

Background: Barrett's esophagus (BE) is the primary risk factor for esophageal adenocarcinoma (EAC). Limited data exists regarding the frequency of histologically confirmed BE by both gender and ethnicity in the United States. The study aim was to determine whether the frequency of histologically confirmed BE varies by ethnicity and gender.

Adult Bowel Preparations for Colonoscopy.

Colon cancer is the third leading cause of cancer among men and women in the United States. Colonoscopy is largely used as a screening tool to detect pre-cancerous polyps and to detect colorectal cancers early. Optimal bowel preparation prior to colonoscopy allows the endoscopist the ability to increase adenoma detection rates and perform the procedure more safely.

African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy.

Background: Barrett's Esophagus (BE) is a pre-malignant condition. Limited data on BE dysplasia prevalence exists among United States ethnic groups.

Aim: The purpose of this study was to determine if the frequency of BE with dysplasia varies among the major ethnic groups presenting to our institution.

Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.

Aim: To determine the effect of ethnicity on the severity of reflux esophagitis (RE) and its complications.

Methods: A retrospective search of the endoscopy database at the University of Florida Health Science Center/Jacksonville for all cases of reflux esophagitis and its complications from January 1 to March 31, 2001 was performed. Inclusion criteria were endoscopic evidence of esophagitis using the LA classification, reflux related complications and self-reported ethnicity.

Sandostatin causing reversible thrombocytopenia.

Esophageal variceal bleeding can be serious or life threatening. Drug-induced thrombocytopenia can further complicate such bleeding episodes. Thrombocytopenia because of sandostatin has been reported in the literature only once previously.